COMPASS Pathways' (NASDAQ: CMPS) Phase 2b study of synthetic psilocybin COMP360 paired with psychological support for Treatment-Resistant Depression (TR
https://www.marijuanamoment.net/oklahoma-house-approves-psilocybin-bill-protecting-patients-from-prosecution-and-promoting-research/
The Oklahoma House of Representatives has approved a bill to promote research into the
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization
Throughout the 2023 session, numerous discussions have been held and various measures have been considered around the legalization of psychedelics.
Let’s go over the latest proposed regulations.
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress.
Numbers show:
John Oliver is back on "Last Week Tonight" and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic-assisted therapy. The show, which aired on Sunday, delves into the history of psychedelics and its potential benefits for mental health.
https://www.marijuanamoment.net/hawaii-senators-approve-bill-to-promote-research-into-psilocybin-and-mdma-therapy/
Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of